Can Steroid Pulse Dose Cause Hypothermia?
Yes, high-dose pulse steroid therapy can cause hypothermia, though this is a rare and underrecognized adverse effect that clinicians should monitor for during treatment.
Evidence for Steroid-Induced Hypothermia
The most direct evidence comes from a 2024 case report 1 documenting steroid-induced hypothermia in a 75-year-old woman with SLE who received high-dose intravenous methylprednisolone (250 mg every six hours). She developed hypothermia (33.4°C) four days after starting treatment, which resolved spontaneously without intervention. This case demonstrates that hypothermia can occur even with isolated presentations and higher cumulative steroid doses.
Historical data from 1978 2 provides additional support: a retrospective study of 17 septic shock episodes showed that a 2-gram Solu-Medrol bolus produced a precipitous temperature fall within four hours in most patients. The hypothermic effect typically lasted approximately 30 hours before temperatures normalized or returned below baseline.
Proposed Mechanisms
The underlying mechanisms remain incompletely understood but likely involve:
- Hypothalamic interference with temperature regulation centers
- Immune dysregulation affecting thermoregulatory pathways
- Endothelial dysfunction (particularly relevant in autoimmune conditions like SLE)
- Glucocorticoid-induced antipyretic effects that may overshoot normal temperature regulation
Clinical Context from Guidelines
While guidelines do not specifically address hypothermia as a steroid complication, they extensively discuss pulse steroid dosing regimens across multiple conditions:
- Kawasaki disease: Methylprednisolone 20-30 mg/kg IV for 3 days 3
- Pemphigus vulgaris: Methylprednisolone 10-20 mg/kg or 250-1000 mg for 2-5 consecutive days 4
- Takayasu arteritis: High-dose oral glucocorticoids preferred over IV pulse therapy unless life-threatening disease 5, 6
Notably, guidelines for perioperative temperature management 7 emphasize that patients are at risk for hypothermia from multiple factors including anesthesia and cold IV fluids, but do not mention steroids as a causative agent—highlighting the underrecognition of this phenomenon.
Clinical Implications and Monitoring
Key monitoring recommendations:
Routine vital sign monitoring should include temperature checks in all patients receiving high-dose pulse steroids
Increased vigilance is warranted in patients with:
- Autoimmune conditions (particularly SLE)
- Septic shock or critical illness
- Cumulative high steroid doses (>1 gram methylprednisolone)
Timing: Hypothermia typically develops within 4-96 hours of steroid administration and may last 8-30 hours
Management approach:
- Most cases resolve spontaneously without intervention 1
- Passive rewarming is generally sufficient
- Avoid aggressive rewarming unless severe hypothermia (<32°C) or hemodynamic instability
- Continue steroid therapy if clinically indicated—hypothermia alone is not an absolute contraindication
Important Caveats
The paradoxical nature of this effect deserves emphasis: steroids are typically associated with fever suppression in infectious contexts 8, but can cause frank hypothermia in certain patients. This may actually represent clinical improvement in septic patients 2, where temperature normalization accompanies general physical improvement.
Do not confuse this with:
- Hypothermia from myxedema coma (severe hypothyroidism) 9—an entirely different mechanism requiring thyroid hormone replacement
- Perioperative hypothermia from environmental/anesthetic factors 7, 10
The rarity of reported cases suggests either true low incidence or significant underreporting. Given that pulse steroids are widely used across multiple specialties, clinicians should maintain awareness of this potential complication and document temperature changes systematically to better characterize risk factors and incidence.